Keywords
telemedicine
telenursing
COVID-19
rheumatic diseases
rheumatic and musculoskeletal diseases
How to Cite
Abstract
Introduction: Telemedicine (TM) reported a great increase from 50% to 150% in health care to RMDs patients during the COVID-19 period, but conflicting opinions in the literature are still present.
Aim: to investigate the results of literature on TM in terms of feasibility (patients’ satisfaction, accessibility, clinical outcomes and barriers), discussing its integration for the future in a nursing perspective during and after COVID-19 period.
Methods: the team that conducted the narrative review was composed by two rheumatology and research nurses (MRM, KEA) and a rheumatologist (MMC), who discussed the relevance of the research question and agreed on the search strategy. Pubmed and Google Scholar databases were searched. The inclusion criteria were: original and quantitative research papers in English with available abstract/full text, on adult patients with RMDs in accordance with the American College of Rheumatology (ACR) and/or European Alliance of Associations of Rheumatology (EULAR) classification criteria, exposed to any kind of technologies during and after COVID19 period, investigating any kind of patient/clinical reported outcomes.
Results: TM could be considered as an integration to standard clinical care in Rheumatology, especially for patients with a stable or low disease activity and rheumatic diagnosis. The choice of the candidates and the assessment of their E-health literacy level are necessary prior including them in TM programs. In addition, healthcare professionals need to be trained in this new modality of providing care.
Conclusion: hybrid models of telehealthcare might be a balanced solution, improving efficiency of the consultation, continuity of care and providing a patient-centred approach.
References
Ziade et al. (2020) The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study, Clinical Rheumatology https://doi.org/10.1007/s10067-020-05428-2
Nelson AJ et al. (2021) A systematic review exploring pre-COVID-19 telehealthcare models used in the management of patients with rheumatological disease, Rheumatology Advances in Practice 2021;00:1–14 https://doi.org/10.1093/rap/rkab073
Koonin LM, Hoots B, Tsang CA, et al. (2020) Trends in the Use of Telehealth During the Emergence of the COVID-19 Pandemic —United States, January–March 2020. MMWR Morb Mortal Wkly Rep. 2020(69):1595–1599.
El Aoufy K, Melis MR, Bellando Randone S et al. (2021) The positive side of the coin: Sars Cov 2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life, Clinical Rheumatology https://doi.org/10.1007/s10067-021-05975-2
Mehrotra A, Ray K, Brockmeyer DM et al. (2020) Rapidly Converting to “Virtual Practices”: Outpatient Care in the Era of Covid-19. NEJM Catal 1(2):1–5
Reeves JJ, Hollandsworth HM, Torriani FJ et al. (2020) Rapid response to COVID-19: Health informatics support for outbreak management in an academic health system. J Am Med Inform Assoc 27(6):853–859
Wei Tang, Leila Khalili, Anca Askanase (2021) Telerheumatology: A Narrative Review. Rheumatology and Immunology research. DOI: 10.2478/rir-2021-0020 • 2(3) • 2021 • 139–145
Devadula S, Langbecker D, Vecchio P et al. (2020) Tele-Rheumatology to Regional Hospital Outpatient Clinics: Patient Perspectives on a New Model of Care. Telemed J E Health. 2020;26(7):912–919.
Bos WH, van Tubergen A, Vonkeman HE. (2021) Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands. Rheumatol Int. 2021 Mar;41(3):565-573. doi: 10.1007/s00296-020-04771-6. Epub 2021 Jan 15. PMID: 33449162; PMCID: PMC7809638.
Mehta B, Jannat-Khah D, Fontana MA et al. (2020) Impact of COVID-19 on vulnerable patients with rheumatic disease: results of a worldwide survey. RMD Open. 2020 Oct;6(3):e001378. doi: 10.1136/rmdopen-2020-001378. PMID: 33011680; PMCID: PMC7722380.
Roberts ET, Mehrotra A. (2020) Assessment of Disparities in Digital Access Among Medicare Beneficiaries and Implications for Telemedicine. Jama Intern Med. 2020;180(10):1386–1389.
Shenoy P, Ahmed S, Paul A et al. (2020) Switching to Teleconsultation for Rheumatology in the Wake of the COVID-19 Pandemic: Feasibility and Patient Response in India. Clin Rheumatol. 2020;39(9):2757–2762.
Foti R, Amato G, Dal Bosco Y et al. (2022) Telemedicine in the Management of Patients with Rheumatic Disease during COVID-19 Pandemic: Incidence of Psychiatric Disorders and Fibromyalgia in Patients with Rheumatoid Arthritis and Psoriatic Arthritis. Int J Environ Res Public Health. 2022 Mar 8;19(6):3161. doi: 10.3390/ijerph19063161. PMID: 35328849; PMCID: PMC8956021.
Richter JG, Chehab G, Schwartz C et al. (2021) The PICASO cloud platform for improved holistic care in rheumatoid arthritis treatment-experiences of patients and clinicians. Arthritis Res Ther. 2021 May 27;23(1):151. doi: 10.1186/s13075-021-02526-7. PMID: 34044850; PMCID: PMC8157758.
Ferucci ED, Day GM, Choromanski TL, Freeman SL. (2022) Outcomes and Quality of Care in Rheumatoid Arthritis With or Without Video Telemedicine Follow-Up Visits. Arthritis Care Res (Hoboken). 2022 Mar;74(3):484-492. doi: 10.1002/acr.24485. Epub 2022 Jan 17. PMID: 33053261.
Sandhu A, Agarwal A, Kaur P et al. (2021) Evaluation of Tele-rheumatology during the COVID-19 Pandemic in Asian Population: A Pilot Study. Int J Telemed Appl. 2021 Sep 0;2021:5558826.
Opinc A. Lukasik Z., Makowska J. (2020) The attitude of Polish rheumatology patients towards telemedicine in the age of the COVID-19 pandemic. Reumatologia. 58. 134-141. 10.5114/reum.2020.96665.
Danila M.I., Gavigan K., Rivera, E. et al. (2022) Patient Perceptions and Preferences Regarding Telemedicine for Autoimmune Rheumatic Diseases Care During the COVID-19 Pandemic. Arthritis Care Res, 74: 1049-1057.
Kavadichanda C, Shah S, Daber A et al. (2021) Tele-rheumatology for overcoming socioeconomic barriers to healthcare in resource constrained settings: lessons from COVID-19 pandemic. Rheumatology (Oxford). 2021 Jul 1;60(7):3369-3379.
Sloan M, Lever E, Harwood R et al. (2022) Telemedicine in rheumatology: a mixed methods study exploring acceptability, preferences and experiences among patients and clinicians. Rheumatology (Oxford). 2022 May 30;61(6):2262-2274. doi: 10.1093/rheumatology/keab796. PMID: 34698822; PMCID: PMC8689882.
Bennell KL, Lawford BJ, Keating C et al. (2022) Comparing Video-Based, Telehealth-Delivered Exercise and Weight Loss Programs With Online Education on Outcomes of Knee Osteoarthritis : A Randomized Trial. Ann Intern Med. 2022 Feb;175(2):198-209. doi: 10.7326/M21-2388. Epub 2021 Nov 30. PMID: 34843383.
So H, Chow E, Cheng IT et al. (2022) Use of telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak: The 6-month results of a randomized controlled trial. Lupus. 2022 Apr;31(4):488-494. doi: 10.1177/09612033221084515. Epub 2022 Mar 7. PMID: 35254169; PMCID: PMC8902321.
Rafiq M.T., Abdul Hamid M.S., Hafiz E. (2021) The effect of rehabilitation protocol using mobile health in overweight and obese patients with knee osteoarthritis: a clinical trial. Adv Rheumatol 61, 63 (2021). https://doi.org/10.1186/s42358-021-00221-4
Howren A., Aviña-Zubieta J.A., Rebi? N. et al. (2020) Virtual rheumatology appointments during the COVID-19 pandemic: an international survey of perspectives of patients with rheumatic diseases. Clin Rheumatol 39, 3191–3193 (2020). https://doi.org/10.1007/s10067-020-05338-3
Latifi R, Doarn CR. Perspective on COVID-19: finally, telemedicine at center stage. Telemed J E Health. 2020;26:1106–9. doi: 10.1089/tmj.2020.0132.
Italian Ministry of Health. National guidelines on Telemedicine. 2012. [Last accessed on 22 Dec 2021]. Available from: http://www.salute.gov.it/portale/temi/p2_6.jsp?lingua=italiano&id=2515&area=eHealth&menu=vuoto&tab=2
NITI Aayog. Telemedicine Practice Guidelines Enabling Registered Medical Practitioners to Provide Healthcare Using Telemedicine. 2020. https://www.mohfw.gov.in/pdf/Telemedicine.pdf. Accessed 20 April 2020.
Solomon DH, Rudin RS. Digital Health Technologies: Oppor¬tunities and Challenges in Rheumatology. Nat Rev Rheumatol. 2020;16(9):525–535.
Costa L, Tasso M, Scotti N, Mostacciuolo E, Girolimetto N, Foglia F, et al. Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort. (2020) Ann Rheum Dis. https ://doi. org/10.1136/annrh eumdi s-2020-21780 6
Morales-Torres J, Aceves-Ávila FJ (2020) Rheumatologists in the COVID-19 era: will there be a new role for the rheumatologist in the care of rheumatic patients? Clin Rheumatol 39(11):3177–3183
Authors retain copyright in their work and do not transfer copyright to the Journal or Publisher.
Authors grant iEditore a non-exclusive right of first publication and a non-exclusive right to publish, distribute, preserve, and make the article available as part of the Interdisciplinary Journal of Nursing and Health.
The published Version of Record is distributed under the Creative Commons Attribution 4.0 International Licence (CC BY 4.0). This licence permits readers and other third parties to copy, share, distribute, reproduce, adapt, translate, and reuse the published article, including for commercial purposes, provided that appropriate credit is given, a link to the licence is supplied, and any changes are indicated.
Authors may share, deposit, reproduce, distribute, adapt, and otherwise reuse their own original work without requesting permission from the Journal or Publisher. The CC BY 4.0 licence governs reuse by readers and other third parties and does not restrict the authors’ exercise of the copyright they retain.
Third-party material that is not included under the article’s Creative Commons licence must be clearly identified in the relevant credit line, figure legend, table note, or accompanying statement and may require separate permission for reuse.